Oak Longevity vs Wellorithm: Price and Access Compared
Oak Longevity vs Wellorithm compares two telehealth platforms that sell compounded GLP-1 medications. Quick verdict: Oak Longevity is the clearer choice for cost-conscious patients due to published low starting prices and no subscription; Wellorithm is stronger for patients who need licensed clinicians in all 50 states.
See Oak Longevity pricing and start
How they differ at a glance: pricing, coverage, and care model
Both providers offer compounded semaglutide and tirzepatide and both note that compounded medications are not FDA-approved. Key differences supported by the source are (1) upfront price transparency and low starting rates at Oak Longevity; (2) nationwide clinician coverage at Wellorithm; (3) asynchronous no-video clinical review and included coaching at Oak versus virtual consultations and ongoing virtual check-ins at Wellorithm; and (4) Oak advertises free health coaching and free shipping while Wellorithm emphasizes free shipping and a 2-minute eligibility quiz.
Pricing transparency and starting costs
Oak Longevity publishes prices: semaglutide from $133/month and tirzepatide from $199/month with a one-price-for-all-dosages approach and no subscription. Wellorithm does not publish fixed pricing on its site; pricing is provided as a personalized quote after the intake quiz, though landing-page material lists starting figures and promotional offsets for certain products in captured evidence. The source states that Wellorithm’s lack of upfront pricing is a drawback for price-sensitive shoppers.
Compare Oak Longevity plans now
State coverage and clinician access
Wellorithm explicitly lists licensed clinicians in all 50 states, which the source frames as a meaningful advantage for patients in states where other platforms lack licensed clinical presence. Oak Longevity does not claim 50-state clinician coverage in the supplied evidence; instead it highlights board-certified physicians in your state reviewing cases, subject to clinician review and medical appropriateness.
Direct comparison table
| Criteria | Oak Longevity | Wellorithm |
|---|---|---|
| Semaglutide starting price | From $133/month | Not published as fixed price; landing evidence lists starting figures |
| Tirzepatide starting price | From $199/month | Starting at $249 per landing evidence; final quote after intake |
| Pricing transparency | Published, one flat price for all dosages | Personalized quote after intake; pricing not plainly published |
| Clinician coverage | Board-certified physicians review cases in your state | Licensed clinicians in all 50 states |
| Consultation model | Asynchronous clinical review, no video call required | Virtual consultations and ongoing virtual check-ins |
| Shipping and extras | Free shipping and free health coaching included | Fast, free shipping; virtual check-ins |
| Regulatory note | Compounded medications not FDA-approved | Compounded medications not FDA-approved |
Care experience and workflow
Oak Longevity emphasizes an online process with a short health questionnaire, asynchronous clinician review, same-day approval for qualifying patients, and no video call requirement. Oak states three-month prescriptions are billed upfront and billing is non-recurring by default. Wellorithm uses a 2-minute quiz to check eligibility, followed by a virtual consultation with a licensed clinician in your state and medication shipped to your home. Wellorithm describes ongoing virtual check-ins to support titration.
Start Wellorithm eligibility quiz
Who each is best for
Based only on the supplied evidence: Oak Longevity is best for cost-conscious patients with uncomplicated health histories who want the most affordable compounded GLP-1 online, no subscription, free coaching, and a process that does not require a video visit. Wellorithm is best for patients who need licensed clinicians in all 50 states and prefer a fully virtual consultation model with ongoing virtual check-ins; however its pricing is provided via personalized quote rather than upfront publishing.
Risks, limits, and regulatory notes
Both providers offer compounded medications, and both sources state that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Oak specifies that patients with BMI below 20 or below 22 without comorbidities may not qualify, and that patients under 18, pregnant, or nursing are ineligible. Wellorithm notes treatment is available only when a licensed clinician determines it is medically appropriate.
Conclusion: Oak Longevity vs Wellorithm
Oak Longevity vs Wellorithm breaks down to a tradeoff between transparent low starting prices and included coaching at Oak and broader 50-state clinician access and a virtual consultation workflow at Wellorithm. Oak is the clearer choice if low published starting prices, no subscription, and included coaching matter most. Wellorithm is the clearer choice if you need guaranteed clinician coverage in all 50 states and prefer live virtual consultations.
Choose Oak Longevity if you want published low starting prices, no subscription, free health coaching, and an asynchronous review process. Choose Wellorithm if you need licensed clinicians in all 50 states and a fully virtual consultation and check-in model.